Recap: Ocugen Q4 Earnings Ocugen (NASDAQ:OCGN) reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Benzinga · Feb 25, 2022
Why Ocugen Shares Are Falling Ocugen Inc (NASDAQ: OCGN) shares are trading lower by 19.6% at $3.40 Wednesday morning after the company announced pricing of a $53.5 million public offering of common stock. Benzinga · Feb 23, 2022
Why Ocugen Shares Are Rising Ocugen Inc (NASDAQ: OCGN) shares are trading higher by 23.8% at $4.28 Tuesday morning after the company announced the FDA lifted its clinical hold on the company's COVID-19 vaccine study in the US. Benzinga · Feb 22, 2022
FDA Lifts Clinical Hold On Ocugen's COVID-19 Vaccine Study In US The FDA has lifted its clinical hold on Ocugen Inc's (NASDAQ: Benzinga · Feb 22, 2022
Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada Ocugen Inc (NASDAQ: OCGN) has Benzinga · Jan 27, 2022